CELECOXIB (CELEBREX®) : Is it a Breakthrough Drug?

UBC Faculty Research and Publications

CELECOXIB (CELEBREX®) : Is it a Breakthrough Drug? Therapeutics Initiative (University of British Columbia)

Description

Therapeutics Letter 31 considers the importance of making unpublished clinical trial data available in the context of the approval of celecoxib. Conclusions: In this case, the only information available to help the clinician decide whether to prescribe celecoxib for their patients are the summary data contained in the abstracts and the promotional material supplied by the manufacturer. Since almost all clinical data about celecoxib remains unpublished and is therefore unavailable for critical appraisal and assessment, it is impossible for the Therapeutics Initiative (TI) to provide timely unbiased information to you and other health professionals. If and when that information becomes available, we will include it in a future Therapeutics Letter.

Item Metadata

Title	CELECOXIB (CELEBREX®) : Is it a Breakthrough Drug?
Alternate Title	Therapeutics Letter 31
Creator	Therapeutics Initiative (University of British Columbia)
Date Issued	1999-09
Description	Therapeutics Letter 31 considers the importance of making unpublished clinical trial data available in the context of the approval of celecoxib. Conclusions: In this case, the only information available to help the clinician decide whether to prescribe celecoxib for their patients are the summary data contained in the abstracts and the promotional material supplied by the manufacturer. Since almost all clinical data about celecoxib remains unpublished and is therefore unavailable for critical appraisal and assessment, it is impossible for the Therapeutics Initiative (TI) to provide timely unbiased information to you and other health professionals. If and when that information becomes available, we will include it in a future Therapeutics Letter.
Subject	Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Osteoarthritis; Pain
Genre	Other
Type	Text
Language	eng
Notes	The UBC TI is funded by the BC Ministry of Health to provide evidence-based information about drug therapy. We neither formulate nor adjudicate provincial drug policies.
Date Available	2023-06-20
Provider	Vancouver : University of British Columbia Library
Rights	Attribution-NonCommercial-NoDerivatives 4.0 International
DOI	10.14288/1.0433610
URI	http://hdl.handle.net/2429/85020
Affiliation	Medicine, Faculty of; Anesthesiology, Pharmacology and Therapeutics, Department of
Peer Review Status	Reviewed
Scholarly Level	Faculty; Researcher
Rights URI	http://creativecommons.org/licenses/by-nc-nd/4.0/
Aggregated Source Repository	DSpace

Open Collections

UBC Faculty Research and Publications